SEC FORM 4
$0.00
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
Acquisition (code M) of 5,470 shares at $0 per share.
Reporting Person Puri Raj K. · Officer Title Chief Regulatory Officer · Transaction Code M
Traded Sep 1, 2026 · Disclosed Sep 3, 2026
Source: SEC Form 4 · 0001104659-26-105100 · filed 2026-09-03 · View filing →